Cinacalcet 90 mg Tablets Recalled for Nitrosamine Impurity Above Safety Limits
Accord Healthcare is recalling Cinacalcet 90 mg tablets nationwide due to nitrosamine impurity (N-nitroso-cinacalcet) at levels exceeding the FDA's acceptable daily intake limit. The issue stems from manufacturing process deviations.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall involves a nitrosamine impurity exceeding the FDA's acceptable daily intake limit—a manufacturing quality issue with direct health risk implications. No illnesses or adverse events have been reported. This meets the High severity threshold as a risk-of-harm product without reported injury.
Plain-English summary
Accord Healthcare, Inc. is recalling Cinacalcet 90 mg tablets distributed nationwide in the United States and Puerto Rico. The recall affects two specific lots: Lot #M2303264 (expiration 01/2026) and Lot #M2306979 (expiration 04/2026). The tablets are manufactured by Intas Pharmaceuticals Limited in India for Accord Healthcare.
The recall was initiated due to Current Good Manufacturing Practice (CGMP) deviations. Testing identified N-nitroso-cinacalcet, a nitrosamine impurity, present at levels above the FDA's acceptable daily intake (ADI) limit. Nitrosamine impurities in pharmaceutical products require strict manufacturing controls to ensure patient safety.
Patients currently taking Cinacalcet from affected lots should contact their pharmacy or healthcare provider to verify whether their medication is part of this recall. Patients should not discontinue use without consulting their healthcare provider, as abrupt discontinuation could affect their medical condition. Affected medication should be returned to the pharmacy where it was dispensed. No adverse health events associated with this impurity have been reported to date.
The recalled product
- Product
- CINACALCET (CINACALCET)
- Brand
- CINACALCET
- Manufacturer
- ACCORD HEALTHCARE, INC.
- Category
- Drug — Prescription Medication
- Hazard
- nitrosamine
- manufacturing-defect
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · CINACALCET
- HighCinacalcet Tablets Recalled for N-Nitroso Impurity Exceeding FDA Safety Limit
FDA (Drugs) · 2024-12-11
- HighPrescription Cinacalcet Tablets Recalled for N-Nitroso Impurity
FDA (Drugs) · 2024-12-11
- HighFDA Recalls Cinacalcet 30mg Tablets for N-nitroso Impurity
FDA (Drugs) · 2024-12-11
- HighCinacalcet tablets recalled for manufacturing impurity exceeding FDA limits
FDA (Drugs) · 2024-11-06
- HighAccord Healthcare Recalls Cinacalcet Tablets Due to Nitrosamine Contamination
FDA (Drugs) · 2024-11-06
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27